Skip to main content

Advertisement

SpringerLink
Log in

Ménétrier’s Disease of the Stomach: A Clinical Challenge

  • Stomach and Duodenum (Joseph R. Pisegna, Section Editor)
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Ménétrier’s disease is a rare hyperproliferative protein-losing gastropathy of the gastric foveolar epithelium. Most common symptoms include epigastric pain with fullness and vomiting, and generalized peripheral edema with hypoalbuminemia. Radiologically, the wall of the gastric body and fundus is diffusely thickened, often with antral sparing. Giant rugal edematous folds are seen on gastroscopy, and histology of biopsy material shows diffuse foveolar hyperplasia with cystic dilatation of the glandular portion of the gastric mucosa in the absence of significant inflammatory infiltrate. The recent discovery of transforming growth factor α overexpression opens the way of epidermal growth factor receptor blockade with cetuximab as first-line treatment modality in severe cases of Ménétrier’s disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •Of importance

  1. Bayerdorffer E, Ritter MM, Hatz R, et al. Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori–is Helicobacter pylori a pathogenic factor in Menetrier’s disease? Gut. 1994;35:701–4.

    Article  PubMed  CAS  Google Scholar 

  2. Beauchamp RD, Barnard JA, McCutchen CM, et al. Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest. 1989;84:1017–23.

    Article  PubMed  CAS  Google Scholar 

  3. Blackstone MM, Mittal MK. The edematous toddler: a case of pediatric Menetrier disease. Pediatr Emerg Care. 2008;24:682–4.

    Article  PubMed  Google Scholar 

  4. Celikel C, Eren F, Gulluoglu B, et al. Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. Pathol Oncol Res. 2007;13:215–26.

    Article  PubMed  Google Scholar 

  5. Coffey RJ, Washington MK, Corless CL, Heinrich MC. Menetrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest. 2007;117:70–80.

    Article  PubMed  CAS  Google Scholar 

  6. Crampton JR, Hunter JO, Neale G, Wight DG. Chronic lymphocytic gastritis and protein losing gastropathy. Gut. 1989;30 Spec No:71-74.

    Google Scholar 

  7. • Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor alpha in the pathogenesis of Menetrier’s disease: supportive evidence form humans and transgenic mice. Gastroenterology. 1992;103:1950–63. This landmark paper represents the start of a new era in the pathophysiology of MD indicating for the first time the link between gastric mucosal TGFα overexpression with increased EGFR signaling and hyperplastic foveolar epithelium in patients with MD.

    PubMed  CAS  Google Scholar 

  8. Elinav E, Korem M, Ofran Y, et al. Hyperplastic gastropathy as a presenting manifestation of systemic lupus erythematosus. Lupus. 2004;13:60–3.

    Article  PubMed  CAS  Google Scholar 

  9. • Fiske WH, Tanksley J, Nam KT, et al. Efficacy of cetuximab in the treatment of Menetrier’s disease. Sci Transl. Med 2009;1:8ra18. This paper reports promising data of the first trial of treatment with a high-affinity EGF receptor blocking antibody(cetuximab) indicating the use of this novel biological agent as first-line therapy in severe protein-losing MD.

    Article  PubMed  Google Scholar 

  10. Friedman J, Platnick J, Farruggia S, et al. Menetrier disease. Radiographics. 2009;29:297–301.

    Article  PubMed  Google Scholar 

  11. Goebel M, Stengel A, Lambrecht NW, Sachs G. Selective gene expression by rat gastric corpus epithelium. Physiol Genomics. 43:237–54

  12. Hsu CT, Ito M, Kawase Y, et al. Early gastric cancer arising from localized Menetrier’s disease. Gastroenterol Jpn. 1991;26:213–7.

    PubMed  CAS  Google Scholar 

  13. Kim J, Cheong JH, Chen J, et al. Menetrier’s disease in korea: report of two cases and review of cases in a gastric cancer prevalent region. Yonsei Med J. 2004;45:555–60.

    PubMed  Google Scholar 

  14. Kovacs AA, Churchill MA, Wood D, et al. Molecular and epidemiologic evaluations of a cluster of cases of Menetrier’s disease associated with cytomegalovirus. Pediatr Infect Dis J. 1993;12:1011–4.

    Article  PubMed  CAS  Google Scholar 

  15. Lam SK, Hui WK, Ho J, et al. Pachydermoperiostosis, hypertrophic gastropathy, and peptic ulcer. Gastroenterology. 1983;84:834–9.

    PubMed  CAS  Google Scholar 

  16. Larsen B, Tarp U, Kristensen E. Familial giant hypertrophic gastritis (Menetrier’s disease). Gut. 1987;28:1517–21.

    Article  PubMed  CAS  Google Scholar 

  17. Lechago J, Genta RM. Stomach and duodenum. In: Damjanov I, Linder J, editors. Anderson’s pathology. New York: Mosby; 1996. 1684.

    Google Scholar 

  18. Lewis JJ, Goldenring JR, Modlin IM, Coffey RJ. Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism. Surgery. 1990;108:220–6. discussion 226–227.

    PubMed  CAS  Google Scholar 

  19. Maffei M, Piessevaux H, Jouret-Mourin A. Polypoid lesions in the stomach and proximal esophagus. Menetrier’s disease of the stomach. Gastroenterology. 140:32, 369.

  20. Ménétrier P. Des polyadenomes gastriques et leur rapport avec le cancer de l’estomac. Arch Physiol Norm Pathol. 1888;1:236–62.

    Google Scholar 

  21. Meuwissen SG, Ridwan BU, Hasper HJ, Innemee G. Hypertrophic protein-losing gastropathy. A retrospective analysis of 40 cases in The Netherlands. The Dutch Menetrier Study Group. Scand J Gastroenterol Suppl. 1992;194:1–7.

    Article  PubMed  CAS  Google Scholar 

  22. Meyer J. Polyposis gastrica (Polyadenomata). JAMA. 1960;1913:61.

    Google Scholar 

  23. Moon SY, Kim KO, Park SH, et al. [Gastritis cystica profunda accompanied by multiple early gastric cancers]. Korean J Gastroenterol. 55:325–30.

  24. Nguyen VX, Nguyen CC, Leighton JA, et al. The association of Menetrier disease with ulcerative colitis: a case report with implications on the pathogenesis of Menetrier disease. Case Rep Gastroenterol. 4:66–70.

  25. Oguri A, Ohmiya N, Taguchi A, et al. Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes. Eur J Gastroenterol Hepatol. 2007;19:561–6.

    Article  PubMed  CAS  Google Scholar 

  26. Ohyama I, Ohmiya N, Niwa Y, et al. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol. 2004;16:693–700.

    Article  PubMed  CAS  Google Scholar 

  27. Rhodes JA, Tam JP, Finke U, et al. Transforming growth factor alpha inhibits secretion of gastric acid. Proc Natl Acad Sci U S A. 1986;83:3844–6.

    Article  PubMed  CAS  Google Scholar 

  28. Rich A, Toro TZ, Tanksley J, et al. Distinguishing Menetrier’s disease from its mimics. Gut. 2010;59:1617–24.

    Article  PubMed  Google Scholar 

  29. Romano M, Polk WH, Awad JA, et al. Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo. J Clin Invest. 1992;90:2409–21.

    Article  PubMed  CAS  Google Scholar 

  30. Saadia B, Salna BH, Mohamed J, et al. Menetrier’s disease and gastric carcinoma. Tunis Med. 2005;83:499–502.

    PubMed  Google Scholar 

  31. Scharschmidt BF. The natural history of hypertrophic gastrophy (Menetrier’s disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med. 1977;63:644–52.

    Article  PubMed  CAS  Google Scholar 

  32. earcy RM, Malagelada JR. Menetrier’s disease and idiopathic hypertrophic gastropathy. Ann Intern Med. 1984;100:565–70.

    PubMed  CAS  Google Scholar 

  33. Takagi H, Jhappan C, Sharp R, Merlino G. Hypertrophic gastropathy resembling Menetrier’s disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J Clin Invest. 1992;90:1161–7.

    Article  PubMed  CAS  Google Scholar 

  34. Tsuji T, Iwahashi M, Nakamori M, et al. Multiple early gastric cancer with gastritis cystica profunda showing various histological types. Hepatogastroenterology. 2008;55:1150–2.

    PubMed  Google Scholar 

  35. Turner JR, Odze RD. Polyps of the stomach. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract, and pancreas. New York: Saunders; 2004. p. 274–5.

    Google Scholar 

  36. Wood MG, Bates C, Brown RC, Losowsky MS. Intramucosal carcinoma of the gastric antrum complicating Menetrier’s disease. J Clin Pathol. 1983;36:1071–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Gastrointestinal Endocrinology, Long Beach VA Medical Center, 5901 East 7th Street, Building 1, Room 200M, Long Beach, CA, 90822-5201, USA

    Nils W. G. Lambrecht

Authors
  1. Nils W. G. Lambrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nils W. G. Lambrecht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lambrecht, N.W.G. Ménétrier’s Disease of the Stomach: A Clinical Challenge. Curr Gastroenterol Rep 13, 513–517 (2011). https://doi.org/10.1007/s11894-011-0222-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-011-0222-8

Keywords

Search

Navigation